InsidersTradesSigma
AddLife AB: insider trades · Finland · FIN-FSA
FI:addlife-abSE0014401378FI·FIN-FSAMcap 17.3Bn€Healthcare
Discover the full directors' dealings record of AddLife AB, a publicly traded company based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, AddLife AB has logged 14 reports. Market capitalisation: €17.3bn. The latest transaction was disclosed on 8 May 2026 — Purchase. Among the most active insiders: Fredrik Dalborg. All data is free.
14
Insider Decl.
0
Thresholds
€252,291
12 ops.
Buy Volume
€5,139
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
142.20 €
Analyst consensus
3 analysts177.00 €Target 193.00 €(+36%)205.00 €
Income statement
Revenue10.44 Bn€
Gross profit3.98 Bn€38% margin
Net income560.0 M€5.5% margin
Valuation
PER (trailing)30.6x
P/Book3.1x
Beta1.57
Balance sheet & cash
Market cap17.33 Bn€
Total debt4.77 Bn€
Free Cash Flow1.11 Bn€
Debt / Equity85%
Profitability & ownership
ROE10.6%
ROA4.1%
% insiders5.2%
% institutions70.9%
Last declaration on 8 May 2026
Declarations14 total
Executives●Purchase28FIN-FSA
€71,6165,500 shares@ €13.02110.0004% mcap36.5% of flow
Aktie
FI:A003Y307-1·
Ideal exit: 2 Feb 2027 (T+270)
Executives●Purchase25FIN-FSA
€2,595200 shares@ €12.9750.0000% mcap9.9% of flow
Aktie
FI:A003W180-1·
Ideal exit: 15 Nov 2026 (T+270)
Executives●Purchase17FIN-FSA
€26,1902,000 shares@ €13.09490.0002% mcap100.0% of flow
Aktie
FI:A003V888-1·
Ideal exit: 8 Nov 2026 (T+270)
Executives●Purchase25FIN-FSA
€14,0391,000 shares@ €14.03870.0001% mcap7.2% of flow
Aktie
FI:A003V702-1·
Ideal exit: 3 Nov 2026 (T+270)
Executives●Purchase35FIN-FSA
€9,107549 shares@ €16.58860.0001% mcap34.8% of flow
Aktie
FI:A003U478-1·
Ideal exit: 1 Sept 2026 (T+270)
Executives●Purchase28FIN-FSA
€13,242800 shares@ €16.55210.0001% mcap6.8% of flow
Aktie
FI:A003U450-1·
Ideal exit: 1 Sept 2026 (T+270)
Executives●Sale17FIN-FSA
€5,139300 shares@ €17.13160.0000% mcap100.0% of flow
Aktie
FI:A003T578-1·
Executives●Purchase22FIN-FSA
€1,789115 shares@ €15.560.0000% mcap6.8% of flow
Aktie
FI:A003R186-1·
Ideal exit: 25 Apr 2026 (T+270)
Executives●Purchase25FIN-FSA
€18,3991,200 shares@ €15.33250.0001% mcap9.4% of flow
Aktie
FI:A003Q694-1·
Ideal exit: 12 Apr 2026 (T+270)
Executives●Other17FIN-FSA
€136,4877,713 shares@ €17.69570.0008% mcap100.0% of flow
Aktie
FI:A003P546-1·
Executives●Purchase32FIN-FSA
€43625 shares@ €17.45610.0000% mcap100.0% of flow
Aktie
FI:A003P357-1·
Ideal exit: 2 Mar 2026 (T+270)
Executives●Purchase28FIN-FSA
€78,7494,500 shares@ €17.49980.0005% mcap40.2% of flow
Aktie
FI:A003P351-1·
Ideal exit: 2 Mar 2026 (T+270)
Executives●Purchase32FIN-FSA
€3,412200 shares@ €17.06210.0000% mcap100.0% of flow
Aktie
FI:A003P348-1·
Ideal exit: 1 Mar 2026 (T+270)
Executives●Purchase26FIN-FSA
€12,716750 shares@ €16.95470.0001% mcap48.5% of flow
Aktie
FI:A003P104-1·
Ideal exit: 21 Feb 2026 (T+270)
14 of 14 declarations